Prospective Study of Apixaban for Primary Prevention of Venous Thromboembolism in Patients with Multiple Myeloma Receiving Immunomodulatory Therapy

被引：1
|
作者：
Cornell, Robert Frank [1 ]
Goldhaber, Samuel Z. [2 ]
Engelhardt, Brian G. [1 ]
Moslehi, Javid [3 ]
Jagasia, Madan [1 ]
Patton, Daryl [4 ]
Harrell, Shelton Lacy [1 ]
Hall, Robert L. [1 ]
Wyatt, Houston [1 ]
Piazza, Gregory [2 ]
机构：
[1] Vanderbilt Univ, Med Ctr, Dept Med, Div Hematol Oncol, Nashville, TN USA
[2] Harvard Med Sch, Div Cardiovasc Med, Brigham & Womens Hosp, Boston, MA USA
[3] Vanderbilt Univ, Med Ctr, Dept Med, Div Cardiovasc Med, Nashville, TN USA
[4] Vanderbilt Inst Clin & Translat Res, Nashville, TN USA
来源：
BLOOD | 2018年 / 132卷
关键词：
D O I：
10.1182/blood-2018-99-112577
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
1233
引用
收藏
页数：4
相关论文
共 50 条
  • [21] SAFETY OF APIXABAN FOR VENOUS THROMBOEMBOLISM PREVENTION IN PATIENTS WITH NEWLY DIAGNOSED GLIOBLASTOMA
    Thomas, Alissa
    Wright, Heather
    Walker, Hannah
    Prasad, Prachi
    Chan, Kelly
    Tipirneni, Eswar
    Goodwin, Andrew
    Holmes, Chris
    NEURO-ONCOLOGY, 2019, 21 : 132 - 132
  • [22] Safety and efficacy of apixaban as thromboprophylaxis in myeloma patients receiving chemotherapy: A prospective cohort study
    Sayar, Zara
    Gates, Carolyn
    Bristogiannis, Sotirios
    Patel, Aisha
    Ogunbiyi, Margaret Olabisi
    Tailor, Anish
    Yong, Kwee
    Thomas, Mari
    THROMBOSIS RESEARCH, 2022, 213 : 27 - 29
  • [23] Rates of venous thromboembolism in multiple myeloma patients undergoing immunomodulatory therapy with thalidomide or lenalidomide: a systematic review and meta-analysis
    Carrier, M.
    Le Gal, G.
    Tay, J.
    Wu, C.
    Lee, A. Y.
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2011, 9 (04) : 653 - 663
  • [24] Lupus Anticoagulant Testing in Patients Receiving Rivaroxaban or Apixaban for the Treatment of Venous Thromboembolism
    Kovacs, Matthew R.
    Lazo-Langner, Alejandro
    Louzada, Martha L.
    Kovacs, Michael J.
    BLOOD, 2016, 128 (22)
  • [25] Apixaban Is Safe and Effective Thromboprophylaxis in Myeloma Patients Treated with Immunomodulatory Therapy
    Storrar, Neill
    Mathur, Abhinav
    Johnson, Peter
    Roddie, Huw
    BLOOD, 2017, 130
  • [26] COMPARATIVE EFFECTIVENESS OF APIXABAN VERSUS WARFARIN FOR THE PREVENTION OF RECURRENT VENOUS THROMBOEMBOLISM AND CARDIOVASCULAR DISEASES IN PATIENTS WITH VENOUS THROMBOEMBOLISM
    Dawwas, G.
    Dietrich, E.
    Park, H.
    VALUE IN HEALTH, 2018, 21 : S57 - S57
  • [27] MELISSE, a large multicentric observational study to determine risk factors of venous thromboembolism in patients with multiple myeloma treated with immunomodulatory drugs
    Leleu, Xavier
    Rodon, Philippe
    Hulin, Cyrille
    Daley, Laurent
    Dauriac, Charles
    Hacini, Maya
    Decaux, Olivier
    Eisemann, Jean-Claude
    Fitoussi, Olivier
    Lioure, Bruno
    Voillat, Laurent
    Slama, Borhane
    Al Jijakli, Ahmad
    Benramdane, Riad
    Chaleteix, Carinne
    Costello, Regis
    Thyss, Antoine
    Mathiot, Claire
    Boyle, Eileen
    Maloisel, Frederic
    Stoppa, Anne-Marie
    Kolb, Brigitte
    Michallet, Mauricette
    Lamblin, Anne
    Natta, Patrick
    Facon, Thierry
    Elalamy, Ismail
    Fermand, Jean-Paul
    Moreau, Philippe
    THROMBOSIS AND HAEMOSTASIS, 2013, 110 (04) : 844 - 851
  • [28] Extending venous thromboembolism secondary prevention with apixaban in cancer patients: The EVE trial
    McBane, Robert D., II
    Loprinzi, Charles L.
    Ashrani, Aneel
    Lenz, Charles J.
    Houghton, Damon
    Zemla, Tyler
    Le-Rademacher, Jennifer G.
    Wysokinski, Waldemar E.
    EUROPEAN JOURNAL OF HAEMATOLOGY, 2020, 104 (02) : 88 - 96
  • [29] Global Prospective Cohort Study of Factors Associated with Venous Thromboembolism in Patients with Lung Cancer Receiving Cancer Therapy
    Kuderer, Nicole M.
    Poniewierski, Marek S.
    Culakova, Eva
    Lyman, Gary H.
    Khorana, Alok A.
    Pabinger, Ingrid
    Agnelli, Giancarlo
    Liebman, Howard A.
    Vicaut, Eric
    Meyer, Guy
    Shepherd, Frances A.
    BLOOD, 2016, 128 (22)
  • [30] Low incidence of thromboembolism in multiple myeloma patients receiving immunomodulatory drugs; a retrospective single-institution analysis
    Takaishi, Koji
    Tsukamoto, Shokichi
    Ohwada, Chikako
    Takeuchi, Masahiro
    Kawasaki, Yohei
    Nagai, Yurie
    Mishina, Tatsuzo
    Yamazaki, Miki
    Isshiki, Yusuke
    Kayamori, Kensuke
    Kimura, Kenji
    Hino, Yutaro
    Oshima-Hasegawa, Nagisa
    Mitsukawa, Shio
    Takeda, Yusuke
    Mimura, Naoya
    Iseki, Tohru
    Nakaseko, Chiaki
    Sakaida, Emiko
    JOURNAL OF THROMBOSIS AND THROMBOLYSIS, 2019, 48 (01) : 141 - 148
12345